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London, Middlesbrough, and Birmingham, United KingdomObjectives The purpose of this study was to compare baseline characteristics and medium-term
prognosis in South Asian and Caucasian patients undergoing percutaneous coronary intervention (PCI).
Background It is unclear whether South Asians undergoing PCI have worse outcomes than
Caucasians.
Methods We performed a retrospective analysis of 279,256 patients undergoing PCI from 2004 to
2011 from the British Cardiovascular Intervention Society national database, of whom 259,318 (92.9%)
were Caucasian and 19,938 (7.1%) were South Asian (South Asian includes patients of Pakistani, Indian,
Bangladeshi, or Sri Lankan ethnic origin). The main outcome measures were in-hospital major adverse
cardiac and cerebrovascular events and all-cause mortality during a median follow-up of 2.8 years
(interquartile range: 1.5 to 4.5 years).
Results South Asians were younger (59.69  0.27 years vs. 64.69  0.13 years, p > 0.0001); more
burdened by cardiovascular risk factors, particularly diabetes mellitus (42.1  1.2% vs. 15.4  0.4%,
p > 0.0001); and more likely to have multivessel coronary disease than Caucasians. In-hospital rates of
major adverse cardiac and cerebrovascular events were similar for South Asians and Caucasians (3.5%
vs. 2.8%, p ¼ 0.40). Unadjusted Kaplan-Meier estimates of all-cause mortality showed better survival for
South Asians compared with Caucasians, after PCI for either acute myocardial infarction or angina.
Age-adjusted analysis revealed increased mortality (hazard ratio: 1.24; 95% conﬁdence interval: 1.18 to
1.30), but after adjustment for the substantial variation in baseline risk factors including diabetes, there
was no signiﬁcant difference between South Asians and Caucasians (hazard ratio: 0.99; 95% conﬁdence
interval: 0.94 to 1.05).
Conclusions In this large, contemporary cohort of patients treated by PCI, South Asians were younger
but had more extensive disease and major risk factors, particularly diabetes. However, after correcting
for these differences, in-hospital and medium-term mortality of South Asians was no worse than that
of Caucasians. This suggests that in South Asians, the high prevalence of diabetes exerts an adverse
inﬂuence on mortality, but ethnicity itself is not an independent predictor of outcome. (J Am Coll
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Abbreviations
and Acronyms
ACS = acute coronary
syndromes
AMI = acute myocardial
infarction
BCIS = British Cardiovascular
Intervention Society
CABG = coronary artery
bypass grafting
CAD = coronary artery
disease
CI = conﬁdence interval
HR = hazard ratio
MACCE = major adverse
cardiac and cerebrovascular
event(s)
NHS = National Health
Service
NICOR = National Institute
for Cardiovascular Outcomes
Research
NSTEMI = non–ST-segment
elevation myocardial
infarction
PCI = percutaneous coronary
intervention
PPCI = primary percutaneous
coronary intervention
STEMI = ST-segment
elevation myocardial
infarction
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363Coronary artery disease (CAD) is more prevalent and pre-
sents earlier in South Asians than other ethnic groups (1,2),
and this is associated with high rates of cardiovascular mor-
tality (1,2). This is observed both in migrant South Asian
populations and in South Asians who continue to reside in
their homeland (2,3). Uncertainty exists about the explana-
tion for this higher coronary mortality in South Asiansd
whether it is because of increased disease prevalence,
increased case fatality, or a combination of the 2 factors.
CAD appears to be more aggressive in patients of South
Asian descent because it presents earlier and with more ex-
tensive angiographic disease (4). The observed accelerated
CAD in South Asians can be explained predominantly by an
excess of traditional risk factors, particularly type 2 diabetes
mellitus, which cluster in South Asians (5), although other
biological hypotheses have been proposed (6–8).Despite these
risk factors, it is not clear whether South Asians diagnosed
with CAD fare worse than Caucasians once they are treated.
Early registries reported that South Asians had higher
cardiovascular mortality after acute myocardial infarction
(AMI) than Caucasians (3,9,10). However, more contem-
porary registry data have suggested that this may not be the
case, reporting similar or better short- and long-term survival
after AMI in South Asians and Caucasians (11–13). It is also
unclear whether South Asians undergoing percutaneous
coronary intervention (PCI) have worse outcomes than
Caucasians. The registry data detailing ethnic difference in
outcomes after PCI for stable CAD are conﬂicting. Although
some studies have suggested that after PCI, both South
Asians and Caucasians have similar short- and long-term
mortality, others have found higher post-procedural adverse
event rates in South Asians (13–15). The small size and short
follow-up period of these studies prevent ﬁrm conclusions
from being drawn.
A single-center study suggested that all-cause mortality
after PCI was no different in South Asians than in Cauca-
sians, regardless of whether PCI was performed for stable
angina or after AMI (11). However, this study reported
outcomes from an urban community with a relatively high
deprivation index (16). Whether this single-center cohort
is representative of the U.K. South Asian population as a
whole is uncertain. We therefore undertook a study using
BCIS (British Cardiovascular Intervention Society) data,
which are collected under the auspices of the NICOR
(National Institute for Cardiovascular Outcomes Research),
to examine the characteristics and outcomes of South Asian
and Caucasian patients undergoing PCI for stable angina
and acute coronary syndrome (ACS) in England and Wales,
United Kingdom. In addition to describing the baseline
characteristics of patients undergoing PCI, we were inter-
ested in describing and understanding the factors that might
affect the outcome of South Asians after PCI. We were
particularly interested to see whether any difference in
outcome could be explained by conventional risk factors.Methods
This was a retrospective, observational cohort study of
279,256 patients to investigate the relationship between
South Asian ethnicity and outcome after PCI in England
and Wales. We used the national database of the BCIS,
which collects mandatory data from all PCI centers in the
United Kingdom.
BCIS-NICOR database. The BCIS–NICOR database (17)
collects data from all hospitals in the United Kingdom that
perform PCI and records information about every procedure
performed. PCI is deﬁned as the
use of any coronary device to
approach, probe, or cross 1
coronary lesions with the inten-
tion of performing a coronary
intervention. The database is
part of the suite of datasets
collected under the auspices of
the NICOR (http://www.ucl.ac.
uk/nicor) and is compliant with
U.K. data protection legislation.
Data are collected prospectively
at each hospital, electronically
encrypted, and transferred online
to a central database where there
is the facility for contemporary
analysis and dissemination. Each
patient entry offers details of the
patient journey, including the
method and timing of admission,
inpatient investigations, results,
treatment, and outcomes. For
patients fromEngland andWales,
patient survival data are obtained
by linkage of patients’ National
HealthService (NHS)numbers to
the Ofﬁce of National Statistics,
which records the date of death
for all patients.
Study population. The study
period was from January 2004 to
July 2011. During this period,
474,078 patients underwent PCI in the United Kingdom,
413,988 of whom were from England and Wales, had NHS
numbers, and comprised the initial population. Of these,
281,989 (68.1%) had ethnicity recorded and complete
datasets and were included in the analysis. A total of 2,733
patients of black or Asian ethnicity, were not included. A
total of 131,120 records (31.7%) did not have ethnicity
documented, and this was the most common reason for
exclusion from the study group. However, analysis of the
outcomes of this excluded group was not signiﬁcantly
different from the study group (data not shown). The study
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364population comprised 279,256 patients of either Caucasian
(n ¼ 259,318; 92.9%) or South Asian (n ¼ 19,938; 7.1%)
origin who underwent PCI between January 2004 and July
2011 (Fig. 1). Indications for PCI included stable angina
and ACS (ST-segment elevation myocardial infarction
[STEMI], non–ST-segment elevation myocardial infarction
[NSTEMI], and unstable angina). Pharmacoinvasive PCI
included both rescue and facilitated PCI after ﬁbrinolysis for
STEMI.
Data collection. For each PCI procedure, a total of 113
variables were collected (the current dataset is version 5.5.6
and is available at http://www.bcis.org.uk). The variables
include patient demographics, indications for PCI, details
of the PCI operators, technical aspects of the PCI proce-
dure, and adverse outcomes including complications until
the time of hospital discharge. Subsequent mortality was
provided by independent tracking via the NHS numberFigure 1. Flowchart of Patients Treated by Percutaneous
Coronary Intervention
Patients were treated between January 2004 and July 2011. The ﬂowchart
describes patient exclusions and ethnic makeup of the study population.
BCIS ¼ British Cardiovascular Intervention Society; NHS ¼ National Health
System; ONS ¼ Ofﬁce of National Statistics.and the U.K. Ofﬁce of National Statistics. The ethnicity
recorded was that declared by the patient. South Asian in-
cludes patients of Pakistani, Indian, Bangladeshi, or Sri
Lankan ethnic (not geographic) origin.
Study outcomes. Procedural complications and in-hospital
major adverse cardiac and cerebrovascular events (MACCE)
were recorded and entered into the database prospectively
(procedural complications at the time of the procedure and
in-hospital complications until the time of discharge). In-
hospital MACCE were deﬁned as death, myocardial infarc-
tion (deﬁned for stable and NSTEMI patients as creatine
kinase level >2 times the upper limit of normal with elevated
creatine kinase-myocardial band or troponin; and deﬁned
for STEMI patients as new ischemic pain with new ST-
segment elevation and further elevation of enzymes, whether
treated with further revascularization therapy or not), stroke,
and the need for urgent target vessel revascularization (PCI
or emergent coronary artery bypass grafting [CABG]). All-
cause mortality data were recorded as of August 10, 2011,
and obtained from the U.K. Ofﬁce of National Statistics.
Ethics. The data were collected as part of a national cardiac
audit exercise, and all patient identiﬁable information was
removed before analysis. Because this analysis was performed
on an anonymous data, the local ethics committee advised us
that ethical approval was not required.
Statistical analysis. Clinical characteristics of South Asian
and Caucasian patients were compared using the Pearson
chi-square test for categorical variables. Normally distributed
continuous variables were compared using the Student
t test, and non-normally distributed continuous variables
were compared using the Mann-Whitney U test. Normality
of distribution was assessed using the Shapiro-Wilks test.
We calculated Kaplan-Meier product limits for cumulative
probability of reaching an endpoint and used the log-rank
test for evidence of a statistically signiﬁcant difference be-
tween the groups. Time was measured from the ﬁrst ad-
mission for a procedure to outcome (all-cause mortality). Cox
regression analysis was used to estimate hazard ratios (HRs)
for the effect of ethnicity in age-adjusted and fully-adjusted
models, based on covariates (p < 0.05) associated with the
outcome. A propensity score analysis was carried out using a
nonparsimonious logistic regression model comparing
Caucasian and South Asian patients. Multiple variables were
included in the model, including all variables with signiﬁcant
interactions. We then undertook a regression adjustment
incorporating the propensity score into a proportional hazard
model as a covariate. We used SPSS for Mac version 19.0
(SPSS, Inc., Chicago, Illinois) for all analyses.
Results
The study population comprised 279,256 patients, 19,938
(7.1%) of whom were Asian and 259,318 (92.9%) were
Caucasian.
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365Patient demographics. South Asians undergoing PCI were
signiﬁcantly younger than Caucasians (Table 1). Despite
this 5-year mean age difference, they had a markedly worse
risk factor proﬁle. South Asians had higher rates of diabetes
(42.1% vs. 15.2%, p < 0.0001) and chronic kidney disease
(3.9% vs. 2.0%, p < 0.0001) and were more likely to be
current smokers. South Asians were also more likely to have
undergone previous coronary revascularization (both PCI
and CABG) despite their younger age at presentation.
Overall, similar proportions of South Asians and
Caucasians presented with ACS, although South Asians
had higher rates of STEMI and subsequent primary
percutaneous coronary intervention (PPCI) but lower
rates of pharmacoinvasive PCI procedures. South Asians
had a greater proportion of severe impairment of left
ventricular function and more frequently presented with
cardiogenic shock. Caucasians had a higher incidence of
previous cerebrovascular accident and peripheral vascular
disease.
Anatomic and procedural characteristics. South Asians had
more extensive coronary disease than Caucasians despite their
younger age (Table 2). There was a higher incidence of
multivessel disease in South Asians compared with Cauca-
sians, with a higher mean number of diseased vessels. Pro-
cedural details were similar for South Asians and Caucasians,
with no difference in the mean number of stents deployed perTable 1. Baseline Characteristics According to Ethnic Gro
Caucasian
(N ¼ 260,423) (N
Age, yrs 64.87  11.37 6
Female 68,490 (26.5)
Stable angina 116,972 (45.1)
Acute MI/ACS 142,246 (54.9) 1
Previous MI 67,391 (26.5)
Previous CABG 21,003 (8.3)
Previous PCI 50,070 (19.3)
Hypertension 133,075 (56.0)
Diabetes mellitus 39,831 (15.4)
Diet-controlled 7,128 (2.7)
Medication 20,956 (8.0)
Insulin 11,747 (4.5)
Hypercholesterolemia 145,795 (61.7) 1
Current smoker 52,656 (23.5)
PVD 12,502 (5.2)
CKD (creatine >200), mmol/l 5,027 (2.0)
Previous CVA 9,445 (4.0)
Left ventricular function
Good 95918 (74.0)
Moderately impaired 26,693 (20.6)
Severely impaired 6,964 (5.4)
Cardiogenic shock 3,849 (1.6)
Values are mean  SD or n (%), unless otherwise noted.
ACS ¼ acute coronary syndromes; CABG ¼ coronary artery bypass graft
MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention; PVlesion (drug-eluting and bare metal stents). However, South
Asians were more likely to undergo multivessel intervention,
or receive a drug-eluting stent, and, when used, South Asians
had a greater number of drug-eluting stents per lesion
compared with Caucasians. South Asians were more likely
than Caucasians to receive glycoprotein IIb/IIIa inhibitors
and to have assessment with either pressure wire or intra-
vascular ultrasound (IVUS).
PCI outcome. PROCEDURAL OUTCOME. Procedural success
was similar for South Asians and Caucasians, with no sig-
niﬁcant difference between the groups for in-hospital
MACCE or any of its components (stroke/ MI/ emergency
bypass surgery/repeat PCI/death) (Table 3). However, there
was a higher rate of coronary dissections, perforations, and
side-branch occlusions in Caucasian patients.
ALL-CAUSE MORTALITY. Median patient follow-up was 2.8
years (interquartile range: 1.5 to 4.5 years). Unadjusted
Kaplan-Meier estimates of all-cause mortality showed better
long-term outcomes for South Asians compared with
Caucasians (p ¼ 0.007) (Fig. 2). However, it should be
noted that the South Asian cohort was signiﬁcantly younger
than the Caucasian cohort. Subgroup analysis by procedural
urgency showed that this difference in mortality was
observed after elective procedures (p ¼ 0.001) but not after
PCI performed for ACS (Fig. 3).up
South Asian
¼ 19,889) p Value
Proportion of Data
Available, % (n)
0.63  11.79 <0.0001 100.0 (279,256)
4,396 (22.2) <0.0001 99.6 (278,278)
8,956 (45.3) 0.7040 99.9 (279,004)
0,830 (54.7) 0.7040 99.9 (280,024)
6,079 (31.2) <0.0001 98.3 (274,481)
2,414 (12.4) <0.0001 97.4 (272,002)
5,581 (28.2) <0.0001 99.9 (279,004)
9,708 (53.7) <0.0001 91.5 (255,574)
8,331 (42.1) <0.0001 99.9 (279,256)
1,035 (5.2) <0.0001 99.9 (279,256)
4,736 (23.8)
2,560 (12.9)
1,269 (62.4) 0.084 91.5 (255,574)
4,944 (28.8) <0.0001 86.0 (240,831)
560 (3.0) <0.0001 91.5 (255,484)
754 (3.9) <0.0001 97.9 (273,366)
576 (3.1) <0.0001 91.5 (255,484)
50.0 (138,974)
6815 (72.5) 0.0015
1,858 (19.8) 0.0510
7,26 (7.7) <0.0001
374 (2.1) <0.0001 91.1 (254,491)
ing; CKD ¼ chronic kidney disease; CVA ¼ cerebrovascular accident;
D ¼ peripheral vascular disease.
Table 2. Procedural Characteristics According to Ethnic Group
Caucasian
(n¼259,318)
South Asian
(n ¼ 19,938) p Value
Proportion of Data
Available
Indication for PCI
ACS 142,718 (54.9%) 10,865 (54.7%) 0.649 100% (279,256)
PPCI 36,396 (14.0%) 3,047 (15.3%) <0.0001
NSTEMI 98,314 (36.3%) 7,449 (37.5%) 0.4145
Pharmaco-invasive 7,670 (3.0%) 326 (1.7%) <0.0001
Facilitated 1,426 (0.6%) 72 (0.4%) 0.0005
Rescue 6,244 (2.4%) 254 (1.3%) <0.0001
Elective 117,440 (45.1%) 9,001 (45.3%) 0.649
Access 96% (268,619)
Femoral 162,992 (65.1%) 11,849 (61.9%) <0.0001
Radial 86,172 (34.4%) 7,174 (37.5%) <0.0001
No. of diseased vessels 79.5% (222,046)
Single-vessel 144,171 (69.6%) 10,160 (64.2%) <0.0001
Multi-vessel 62,637 (30.4%) 5,653 (35.9%) <0.0001
Mean vessels 1.11  0.8 1.20  0.9 <0.0001
Single vessel intervention 207,438 (84.6%) 15,434 (83.1%) <0.0001 94.6% (263,707)
Target vessel
Right coronary artery 70,633 (28.8%) 4,603 (24.8%) <0.0001 94.6% (263,707)
Left main coronary artery 2,421 (1.0%) 172 (0.9%) 0.4330
Left anterior descending (LAD) 86,722 (35.4%) 6,735 (36.3%) 0.0164
Left circumﬂex coronary artery 36,085 (14.7%) 3,033 (16.3%) <0.0001
Saphenous vein graft 11,577 (4.7%) 891 (4.8%) 0.6622
Multi-vessel intervention 37,692 (15.4%) 3,143 (16.9%) <0.0001
IVUS 7,552 (3.3%) 688 (3.8%) <0.0001 89.2% (248,542)
Pressure wire 14,102 (6.1%) 1,262 (7.0%) <0.0001 89.2% (248,542)
No. of stents used 1.52  1.04 1.52  1.07 0.869 97.9% (273,126)
DES 151,562 (61.5%) 13,009 (68.4%) <0.0001 95.2% (265,428)
DES used 1.03  1.11 1.15  1.11 <0.0001 95.2% (265,428)
Glycoprotein IIb/IIIa inhibitor 74,101 (31.5%) 6,460 (35.8%) <0.0001 90.8% (253,439)
Values are n (%) or mean  SD.
DES ¼ drug-eluting stent(s); IVUS ¼ intravascular ultrasound; NSTEMI ¼ non–ST-segment elevation myocardial infarction; PPCI ¼ primary
percutaneous coronary intervention; other abbreviations as in Table 1.
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366ACS breakdown. Although there was no difference in the
long-term mortality of South Asian and Caucasian patients
after ACS as a whole, splitting by ACS subgroups revealed
signiﬁcantly higher unadjusted long-term mortality after
PPCI for STEMI in Caucasians compared with South
Asians (Fig. 4) but no difference in other subgroups. There
was no difference after NSTEMI or pharmacoinvasive PCI.
Again, it should be noted that the South Asian cohort was
signiﬁcantly younger than the Caucasian cohort.
Diabetes mellitus. Splitting the patients into subgroups
based on diabetic status demonstrated that for both dia-
betic and nondiabetic patients, there was signiﬁcantly
higher unadjusted all-cause mortality for the Caucasian
group (Fig. 5). Once again, the age difference should be
noted. We also analyzed patients according to their diabetic
treatment modality (diet, tablet, or insulin based). For
all 3 of these categories, we found a similar higher rate
of diabetes in South Asians compared with Caucasians
(Table 1). There were similar higher unadjusted all-causemortality rates for Caucasians in each of these diabetic
subgroups (data not shown) as for the diabetic population
as a whole.
Cox analysis. The age-adjusted Cox analysis showed an
increase in the hazard of death for South Asians compared
with Caucasians (HR: 1.24; 95% conﬁdence interval
[CI]: 1.18 to 1.30), but the difference was lost with mul-
tiple adjustment (HR: 0.99; 95% CI: 0.94 to 1.05).
All covariates in this model and their HRs are shown in
Figure 6.
In the subgroup of patients in whom left ventricular
systolic function was documented on discharge (138,974,
50.0%), there remained no association between ethnicity
and mortality, even after correcting for left ventricular sys-
tolic function (adjusted HR: 1.03; 95% CI: 0.93 to 1.08).
Additionally, after regression adjustment incorporating
the propensity score into a proportional hazard model as a
covariate (calculated from age, ACS presentation, sex, dia-
betes, hypertension, hypercholesterolemia, previous CABG,
Table 3. In-Hospital Outcomes and Complications After PCI According to Ethnic Group
Caucasian
(n ¼ 259,318)
South Asian
(n ¼ 19,938) p Value
Proportion of Data
Available, % (n)
In-hospital
MACCE 5,422 (2.2) 451 (2.4) 0.0709 94.7 (263,883)
Death 2,885 (1.2) 239 (1.3) 0.2184
Q-wave MI 1,307 (0.5) 110 (0.6) 0.3353
Reintervention PCI 723 (0.3) 67 (0.4) 0.1399
CVA 263 (0.1) 16 (0.1) 0.4499
Emergency CABG 244 (0.1) 19 (0.1) 0.9798
Coronary dissection/perforation 5,857 (2.5) 297 (1.6) <0.0001 90.1 (250,949)
Aortic dissection 133 (0.1) 10 (0.1) 0.9572
Side branch occlusion 1,770 (0.8) 98 (0.5) 0.0011
No/slow ﬂow 2,618 (1.1) 176 (1.0) 0.0619
Heart block 473 (0.2) 33 (0.2) 0.5982
DC cardioversion 727 (0.3) 44 (0.2) 0.1182
Arterial complications 1,312 (0.5) 78 (0.4) 0.3353
Values are n (%), unless otherwise noted.
DC ¼ direct current; MACCE ¼ major adverse cardiac and cerebrovascular events; other abbreviations as in Table 1.
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367previous PCI, previous myocardial infarction, previous cere-
brovascular accident, peripheral vascular disease, access site,
procedural success, chronic total occlusion, multivessel disease,
chronic kidney disease, and glycoprotein IIb/IIIA inhibitor
use), there was no difference in mortality between South
Asians and Caucasians (HR: 0.99; 95% CI: 0.93 to 1.05).
Discussion
This study, using data from a large national PCI registry
of consecutive cases in England and Wales over a 7-yearFigure 2. Kaplan-Meier Curves Showing Cumulative Probability of
All-Cause Mortality
Kaplan-Meier curves showing higher unadjusted cumulative probability of all-
cause mortality after PCI in Caucasians compared to South Asians.period, is the largest observational study to date comparing
the outcomes of South Asians and Caucasians after PCI.
We describe a cohort of South Asian patients who are
fundamentally different from their Caucasian counter-
parts. Despite being on average 5 years younger, the South
Asians had more extensive disease, more complex cardiac
histories, and an alarming rate of diabetes mellitus (42%
vs. 15% for Caucasians). Although it is often assumed
that South Asian patients will have a higher mortality
than Caucasians after PCI, we have found that the un-
adjusted long-term mortality for South Asians was actu-
ally lower than that in Caucasians, mainly as a result of
their much younger age at presentation. After correction
for age alone, mortality was higher in the South Asians,
but after adjustment for the other signiﬁcant differences
between the 2 groups (in particular, the >3-fold greater
prevalence of diabetes), we observed no overall difference
in the long-term mortality of South Asians versus Cau-
casians. This is consistent with other contemporary
studies examining the effect of ethnicity on outcomes
after PCI (11,13,15).
Despite a younger age, this cohort of South Asians had a
higher prevalence of both diabetes and chronic kidney
disease and a higher rate of smoking, all of which are
strongly associated with premature vascular disease. This is
the likely explanation why South Asians present with such
extensive coronary disease and at a younger age than
Caucasians (7). Conversely, South Asians were less likely to
have hypertension, previous stroke, or peripheral vascular
disease. Immigration is a dynamic process, and with the
increase in rates of obesity globally (18), it is likely that the
risk factor proﬁle of patients will continue to change with
time. This would be an extremely important area for
further study in view of our ﬁndings primarily related to the
Figure 3. Kaplan-Meier Curves Showing Cumulative Incidence of All-Cause Mortality
(A) Kaplan-Meier curves showing higher cumulative incidence of unadjusted all-cause mortality after elective percutaneous coronary intervention (PCI) for Caucasian
compared to South Asian patients. (B) Kpaln-Meier curves showing similar cumulative incidence of all-cause mortality after PCI for acute coronary syndromes for
Caucasian and South Asian patients (unadjusted data).
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368very high rates of diabetes in our South Asian population.
Additionally, the degree to which diabetes in young South
Asians represents a ﬁxed genetic predisposition versus a
clinically modiﬁable or preventable risk factor also deserves
further study.
In this cohort, STEMI was a more common presentation
among South Asians, and consequently South Asians were
more likely to undergo PPCI than Caucasians. As withFigure 4. Kaplan-Meier Curves Showing Cumulative Incidence of
All-Cause Mortality After PPCI
The curves show a higher incidence of cumulative unadjusted all-cause
mortality after PPCI for Caucasian compared to South Asian patients. LR ¼
log-rank; PPCI ¼ primary percutaneous coronary intervention.previous research, the largest unadjusted mortality difference
between South Asians and Caucasians was after PPCI, with
Caucasians faring worse (12). This difference is primarily
explained by the age difference between the 2 groups. South
Asians presenting with STEMI were on average 6 years
younger (data not shown) than their Caucasian counterparts.
However, despite the younger age of the South Asians, it is
again worth emphasizing the signiﬁcant difference in their
risk factor proﬁle compared with Caucasians. For example,
42% of South Asians presenting with STEMI were diabetic
compared with 15% of Caucasians. After correcting for
these signiﬁcant differences in age and comorbidity, there
was no longer a signiﬁcant difference in outcomes between
South Asians and Caucasians. This analysis suggests that the
observed differences between these 2 populations can be
explained purely on the basis of conventional risk factors for
coronary disease and that ethnicity itself does not appear to
be an independent predictor of outcome. Our data do not
suggest, from a PCI perspective, that there is no difference
between the 2 populations; rather, we imply that the dif-
ferences in outcome that we describe appear to be explained
by conventional risk factors. Essentially, being South Asian
implies being much more likely to have major risk factors,
particularly diabetes, and carrying the adverse prognostic
effects of this.
Although our data suggest that this difference in outcome
can be explained by these conventional risk factors, other
variables may also be contributing to the effect. Socioeco-
nomic status can affect the outcome of numerous medical
conditions (19). However, recent work from the United
Kingdom has suggested that low socioeconomic status does
not disproportionately affect outcome of South Asians (13).
Figure 5. Kaplan-Meier Curves Showing Cumulative Incidence of
All-Cause Mortality After PCI for Patients With Diabetes Mellitus
Kaplan-Meier curves showing a higher incidence of cumulative all-cause
mortality after PCI for diabetic Caucasian and South Asian patients compared
to nondiabetic ethnicity matched groups (p<0.0001) (unadjusted data).
PCI ¼ percutaneous coronary intervention.
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369Likewise, secondary prevention prescription and compliance
may be different between our 2 populations. However, data
from a similar population in the United Kingdom actually
suggests that secondary prevention prescription may actually
be better in South Asians (13), and this was also shown in
a Canadian study (20). We did not investigate the impact ofFigure 6. Hazard Ratios for All-Cause Mortality
Multivariate hazard ratios of the Cox analysis for all cause mortality after percutaneo
association between ethnicity and all cause mortality. CABG ¼ coronary artery bypas
cerebrovascular accident; MI ¼ myocardial infarction; NA ¼ not applicable; PVD ¼ pcompliance with secondary prevention in our population on
outcome. However, there are some data that suggest that the
compliance of some aspects of secondary prevention may be
lower in South Asian patients, and conceivably this could
have inﬂuenced the results.
A contemporary North American study reported that
South Asians have improved survival after AMI compared
with Caucasians (12). It is difﬁcult to compare our results
with those of this study because the U.K. South Asian
population comprises much high proportions of Pakistani
and Bangladeshi South Asians than the North American
South Asian population, the majority of whom originate
from further south on the Indian subcontinent (21,22). Both
Pakistani and Bangladeshi South Asians appear to have a
higher mortality from cardiovascular disease than Indian
South Asians (3).
A recent meta-analysis and national cohort study has also
come to conclusions similar to ours regarding the association
of outcome with South Asian status (13). Although South
Asian ethnicity is associated with a higher incidence of
CAD, there appears to be a lower mortality once the CAD
presents compared with Caucasian ACS patients. These
data are in accord with our ﬁndings in an unselected PCI
cohort including elective as well as ACS patients.
It is possible that South Asians have different access to
healthcare pathways, and this may inﬂuence their outcome.
However, in the United Kingdom, ethnicity is not associated
with inequality of access to chest pain assessment services
(23), and national registry data provide no evidence of
undertreatment of South Asians with ACS (24,25). We didus coronary intervention (PCI) with 95% conﬁdence intervals (CIs) showing no
s grafting; CKD ¼ chronic kidney disease; CTO ¼ chronic total occlusion; CVA ¼
eripheral vascular disease.
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370observe higher rates of pharmacoinvasive PCI in the
Caucasian group, implying that South Asians may be more
likely to receive PPCI for STEMI as the initial management
strategy. Although we did not explore this, this difference
may be related to the geographic distance of patients to heart
attack centers. In the United Kingdom, the majority of
South Asians reside in urban areas and therefore are closer to
regional heart attack centers (26). This may give them better
access to PPCI. Our study focused on PCI patients, and
hence we do not have data on patients treated primarily by
ﬁbrinolysis for STEMI. However, U.K. studies (from the
ﬁbrinolysis era) suggested that access to ﬁbrinolysis may be
better for South Asian patients than Caucasians, supporting
the suggestion that South Asians had greater access to PPCI
in the PPCI era. Additionally, our analysis of patients
treated with pharmacoinvasive approaches had similar out-
comes for both ethnic groups.
We also know that South Asians in the United Kingdom
have similar survival rates after cardiac arrest (27), sug-
gesting that there is unlikely to be a difference in pre-
hospital survival, which could conceivably bias results. Our
study conﬁrms that with contemporary treatment equitably
applied across ethnic groups, case fatality rates for patients
with established CAD undergoing PCI are no higher
for South Asians than for Caucasians. We can therefore
speculate that the presentation of CAD at a younger age
in South Asians may enable the effective implementation
of preventive measures. An emphasis on education reinforc-
ing that South Asians are more likely to develop diabetes
and premature CAD along with speciﬁc drug, dietary, and
lifestyle interventions are important steps in improving
outcomes (28,29).
The strengths of this dataset are that it includes a
comprehensive collection of all PCI procedures performed
in England and Wales. Therefore, it includes treatment of
all patients, low- and high-risk alike, and contains a large
number of procedures. Most importantly for this study, it
includes a high number of South Asian patients. Mortality
tracking in England and Wales is particularly robust based
on ofﬁcial U.K. Ofﬁce of National statistics data. The uni-
variate, multivariate, and propensity analyses highlight the
quality of the data with well-recognized predictors of mor-
tality associated with adverse outcomes in our dataset. The
univariate, multivariate, and propensity analysis highlights
the quality of the data with well-recognized predictors of
mortality associated with adverse outcome in our data set
with event rates similar to other large published cohorts of
PCI patients (30).
Study limitations. Despite these strengths, there are a
number of important limitations common to observational
studies of this type. The BCIS data collection shares the
weaknesses of other national registries as there is always a
balance between the size of the dataset and the willingness
and ability to collect it accurately. Although 32% of patientswere recorded as unknown ethnicity and hence not included
in the analysis, we found no difference in outcome compared
with the study group (data not shown). National datasets
rely on self-reporting of adverse events, and there is no
external validation of these results, although the mortality
data are robust as they are from the U.K. Ofﬁce of National
Statistics. Although the assessment of mortality is very
strong and particularly appropriate for interventions aimed
at reducing mortality (such as PCI for ACS), some other
aspects of late patient outcome are not assessed, such as
recurrent myocardial infarction, need for later additional
revascularization, and follow-up data on quality of life and
angina status are not recorded. Unfortunately, we only have
all-cause mortality as an endpoint, and therefore we cannot
analyze cardiac death speciﬁcally. We cannot account for
the effects of residual confounding or selection bias caused
by exclusion of 32% of patients with incomplete datasets.
Categorizing patients as South Asian may obscure important
outcome differences between the different constituent ethnic
subgroups (2). We accept that there is likely to be consid-
erable heterogeneity within the South Asian population.
Although this may not be a major factor affecting outcome
after myocardial infarction in the United Kingdom, the ef-
fect of different subgroups of South Asians would require
further study in the PCI population (13). As this was an
observational study, there may also be confounding factors
that we have been unable to control for. This may include
adherence to evidence-based therapies (e.g., medication),
which has been shown to be associated with outcome,
although prescription of secondary prevention may actually
be slightly higher in South Asians (13).
Conclusions
In the largest published contemporary cohort of patients
undergoing PCI, we describe a South Asian population that,
although being a mean of 5 years younger than Caucasian
controls, has a 42% rate of diabetes and more extensive
coronary disease. As expected, the younger South Asian
cohort has a lower unadjusted mortality. Age-adjusted data
show a higher mortality after PCI, but there was no dif-
ference between South Asians and Caucasians in long-term
case fatality rates after correction for baseline characteristics.
This adds further weight to the emerging consensus that the
excess coronary mortality for people of South Asian origin
largely reﬂects their propensity for developing premature
diabetes. Corrected case fatality rates are not different from
those of Caucasian patients.
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